Targeted Medical Pharma, Inc. announced earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported net loss of $974,470 compared to $270,277 a year ago. Total revenue was $1.8 million, compared to $2.8 million during the three months ended March 31, 2013.

Adjusted LBITDA was $0.6 million, compared to $0.1 million during the three months ended March 31, 2013. During the three months ended March 31, 2014 and 2013, net loss consisted of a significant amount of non-cash charges. Due to the impact of these non-cash charges on reported net loss, the company place greater emphasis in adjusted EBITDA.